{"pmid":32358817,"title":"Dramatic improvement after Tocilizumab of a severe COVID-19 in a child with sickle cell disease and acute chest syndrome.","text":["Dramatic improvement after Tocilizumab of a severe COVID-19 in a child with sickle cell disease and acute chest syndrome.","Am J Hematol","Odievre, Marie-Helene","de Marcellus, Charles","Ducou Le Pointe, Hubert","Allali, Slimane","Romain, Anne Sophie","Youn, Jenny","Taytard, Jessica","Nathan, Nadia","Corvol, Harriet","32358817"],"journal":"Am J Hematol","authors":["Odievre, Marie-Helene","de Marcellus, Charles","Ducou Le Pointe, Hubert","Allali, Slimane","Romain, Anne Sophie","Youn, Jenny","Taytard, Jessica","Nathan, Nadia","Corvol, Harriet"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358817","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ajh.25855","e_drugs":["tocilizumab"],"topics":["Case Report"],"weight":1,"_version_":1666138495320588291,"score":9.490897,"similar":[{"pmid":32282956,"title":"Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.","text":["Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.","Am J Hematol","De Luna, Gonzalo","Habibi, Anoosha","Deux, Jean Francois","Colard, Martin","d'Alexandry d'Orengiani, Anne Laure Pham Hung","Schlemmer, Frederic","Joher, Nizar","Kassasseya, Christian","Pawlotsky, Jean Michel","Ourghanlian, Clement","Michel, Marc","Mekontso-Dessap, Armand","Bartolucci, Pablo","32282956"],"journal":"Am J Hematol","authors":["De Luna, Gonzalo","Habibi, Anoosha","Deux, Jean Francois","Colard, Martin","d'Alexandry d'Orengiani, Anne Laure Pham Hung","Schlemmer, Frederic","Joher, Nizar","Kassasseya, Christian","Pawlotsky, Jean Michel","Ourghanlian, Clement","Michel, Marc","Mekontso-Dessap, Armand","Bartolucci, Pablo"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282956","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/ajh.25833","e_drugs":["tocilizumab"],"topics":["Case Report"],"weight":1,"_version_":1666138491452391424,"score":64.53911},{"pmid":32243621,"title":"COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.","text":["COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.","Am J Hematol","Beerkens, Frans","John, Mira","Puliafito, Benjamin","Corbett, Virginia","Edwards, Colleen","Tremblay, Douglas","32243621"],"journal":"Am J Hematol","authors":["Beerkens, Frans","John, Mira","Puliafito, Benjamin","Corbett, Virginia","Edwards, Colleen","Tremblay, Douglas"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243621","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1002/ajh.25809","topics":["Case Report"],"weight":1,"_version_":1666138492120334337,"score":56.556423},{"pmid":32267016,"title":"Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).","text":["Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).","Am J Hematol","Nur, Erfan","Gaartman, Aafke E","van Tuijn, Charlotte F J","Tang, Man Wai","Biemond, Bart J","32267016"],"journal":"Am J Hematol","authors":["Nur, Erfan","Gaartman, Aafke E","van Tuijn, Charlotte F J","Tang, Man Wai","Biemond, Bart J"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267016","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ajh.25821","topics":["Case Report"],"weight":1,"_version_":1666138491882307584,"score":50.93514},{"pmid":32314798,"title":"COVID-19 Infection in Patients with Sickle Cell Disease.","text":["COVID-19 Infection in Patients with Sickle Cell Disease.","Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, has spread to 184 countries with almost 1.5 million cases as of mid-April 2020 since first reported (1). The clinical features of this disease are not completely understood, however severe illness is thought to predominantly occur in adults with advanced age and those with underlying comorbidities (2). Sickle cell disease (SCD), an immunocompromised condition, puts patients at higher risk for respiratory infections and subsequent pulmonary complications such as acute chest syndrome (ACS) (3).","Br J Haematol","Hussain, Faiz A","Njoku, Franklin U","Saraf, Santosh L","Molokie, Robert E","Gordeuk, Victor R","Han, Jin","32314798"],"abstract":["Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, has spread to 184 countries with almost 1.5 million cases as of mid-April 2020 since first reported (1). The clinical features of this disease are not completely understood, however severe illness is thought to predominantly occur in adults with advanced age and those with underlying comorbidities (2). Sickle cell disease (SCD), an immunocompromised condition, puts patients at higher risk for respiratory infections and subsequent pulmonary complications such as acute chest syndrome (ACS) (3)."],"journal":"Br J Haematol","authors":["Hussain, Faiz A","Njoku, Franklin U","Saraf, Santosh L","Molokie, Robert E","Gordeuk, Victor R","Han, Jin"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314798","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/bjh.16734","topics":["Case Report"],"weight":1,"_version_":1666138493470900225,"score":46.764565}]}